Ristow H J
Dermatology Service, Veterans Affairs Medical Center, Decatur, GA 30033, USA.
Growth Regul. 1996 Jun;6(2):96-109.
Epidermal growth factor (EGF) and insulin are the most widely used growth factors (GFs) in human keratinocyte cultures. Insulin is supposed to exert its growth-promoting activity in this system through the insulin-like growth factor-I (IGF-I) receptor. In order to obtain more information about the contribution of EGF and IGF-I to the proliferation of keratinocytes, the effect of each factor on DNA synthesis was studied with 3H thymidine incorporation in an otherwise GF-free system. Both factors are able to initiate DNA synthesis, DNA synthesis peaks 18-20 h after the addition of each factor, and neither factor influences significantly the binding of the other to the respective receptor. IGF-I is the more potent growth factor, and IGF-I-stimulated cells enter the S-phase regularly approximately 3 h earlier than EGF-stimulated keratinocytes (7-9 h vs 10-12 h). However, IGF-I-stimulated DNA synthesis can be completely turned off by the addition of the monoclonal antibody (mAb) to the EGF receptor LA1. This inhibition cannot be reversed by higher IGF-I concentrations, but only by the addition of EGF to the culture medium. These results may suggest the presence of two keratinocyte populations, one responding to EGF and one to IGF-I, with an additional signal from the EGF receptor, or they may be explained on the basis of only one cell population for which EGF acts as a "competence' factor and IGF-I as a "progression' factor.
表皮生长因子(EGF)和胰岛素是人类角质形成细胞培养中使用最广泛的生长因子(GFs)。胰岛素被认为在该系统中通过胰岛素样生长因子-I(IGF-I)受体发挥其促生长活性。为了获得更多关于EGF和IGF-I对角质形成细胞增殖贡献的信息,在一个无其他生长因子的系统中,通过3H胸腺嘧啶核苷掺入法研究了每种因子对DNA合成的影响。两种因子均能启动DNA合成,在添加每种因子后18 - 20小时DNA合成达到峰值,且两种因子均未显著影响另一种因子与各自受体的结合。IGF-I是更有效的生长因子,IGF-I刺激的细胞比EGF刺激的角质形成细胞提前约3小时(7 - 9小时对10 - 12小时)定期进入S期。然而,通过添加针对EGF受体LA1的单克隆抗体(mAb),IGF-I刺激的DNA合成可被完全阻断。这种抑制不能通过更高浓度的IGF-I逆转,而只能通过向培养基中添加EGF来逆转。这些结果可能表明存在两种角质形成细胞群体,一种对EGF有反应,另一种对IGF-I有反应,且来自EGF受体有额外信号,或者也可以基于仅一种细胞群体来解释,即对于该群体,EGF作为“能力”因子,IGF-I作为“进展”因子。